Announcements and Notices
[Other - Business Update] VOLUNTARY ANNOUNCEMENT - RC198 RECEIVED ETHICS APPROVAL FOR THE PHASE I CLINICAL TRIAL IN AUSTRALIA, AND THE COMPANY WILL INITIATE THE STUDY TO TREAT PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS
08
2023.05
